Health-related quality of life impairment is equal for antiphospholipid syndrome whether primary or associated with systemic lupus erythematosus
Primary APS and APS secondary to SLE lead to equal impairment in HRQoL. Diagnosis and proper management of all patients with APS are essential to prevent thrombosis and miscarriages, which ultimately will lead to longer survival with optimal life quality.
Authors
- Marzena Olesińska (ORCID: https://orcid.org/0000-0003-3028-1061)
- Ewa Haładyj (ORCID: https://orcid.org/0000-0002-5677-6292)
- Tomasz Wysocki (ORCID: https://orcid.org/0000-0002-1704-4937)
- Agata Matusiewicz (ORCID: https://orcid.org/0000-0001-6117-0853)
Institutions
- Eli Lilly (United States) (US)
- National Institute of Geriatrics, Rheumatology and Rehabilitation (PL)
Publication Details
- Journal
- Reumatologia/Rheumatology
- Published
- 2024-09-16
- DOI
- https://doi.org/10.5114/reum/192028
- Citations
- 1
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.47